15 companies backed by Omega Funds, including Scorpion Therapeutics, Third Arc Bio, Windward Bio. Each links to its full verified cap-table syndicate.
Omega Funds accounts for 48 tracked companies with verified cap-table data, 48 of which disclose round sizes totalling $11B. The median disclosed raise is $165M, and the largest is Morphic Therapeutic at $3.2B, ahead of Sana Biotechnology ($700M) and Alumis ($529M).
The names that recur most often on these portfolio cap tables are Omega Funds (48 companies), Cormorant Asset Management (7 companies), Jeito Capital (6 companies), Novartis Venture Fund (6 companies), Atlas Venture (6 companies), Surveyor Capital (6 companies). By latest disclosed round, the market skews Series A (18), Series B (15), Series C (6), Growth (3).
Companies tracked: 48
Disclosed funding total: $11B across 48 companies
Median disclosed raise: $165M
Largest raise: Morphic Therapeutic — $3.2B
Stage mix: Series A 18 · Series B 15 · Series C 6 · Growth 3
